Katarzyna Pogoda
Katarzyna Pogoda
MD PhD, National Research Institute of Oncology, Warsaw, Poland
Zweryfikowany adres z pib-nio.pl
Cytowane przez
Cytowane przez
Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT)
A Niwińska, M Murawska, K Pogoda
Annals of Oncology 21 (5), 942-948, 2010
Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients
K Pogoda, A Niwińska, M Murawska, T Pieńkowski
Medical oncology 30, 1-8, 2013
Breast cancer subtypes and response to systemic treatment after whole‐brain radiotherapy in patients with brain metastases
A Niwińska, M Murawska, K Pogoda
Cancer 116 (18), 4238-4247, 2010
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations
M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ...
Journal of Clinical Oncology 38 (26), 3012-3023, 2020
Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis
K Pogoda, A Niwińska, E Sarnowska, D Nowakowska, ...
Journal of oncology 2020, 2020
Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer
J Mierzynska, M Taye, M Pe, C Coens, F Martinelli, K Pogoda, G Velikova, ...
European Journal of Cancer 125, 69-82, 2020
Factors influencing survival in patients with breast cancer and single or solitary brain metastasis
A Niwińska, K Pogoda, M Murawska, P Niwiński
European Journal of Surgical Oncology (EJSO) 37 (7), 635-642, 2011
Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM)
A Niwińska, K Pogoda, W Michalski, M Kunkiel, A Jagiełło-Gruszfeld
Journal of neuro-oncology 138, 191-198, 2018
Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes
A Niwińska, W Olszewski, M Murawska, K Pogoda
Journal of Neuro-oncology 105, 547-553, 2011
Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types
JZ Musoro, C Coens, MAG Sprangers, Y Brandberg, M Groenvold, ...
European Journal of Cancer 188, 171-182, 2023
Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants
M Lambertini, M Ceppi, AS Hamy, O Caron, PD Poorvu, E Carrasco, ...
NPJ breast cancer 7 (1), 16, 2021
Limitations of systemic oncological therapy in breast cancer patients with chronic kidney disease
A Bednarek, J Mykała-Cieśla, K Pogoda, A Jagiełło-Gruszfeld, M Kunkiel, ...
Journal of Oncology 2020, 2020
Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study
M Lambertini, E Blondeaux, E Agostinetto, AS Hamy, HJ Kim, A Di Meglio, ...
JAMA 331 (1), 49-59, 2024
Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer
M Condorelli, M Bruzzone, M Ceppi, A Ferrari, A Grinshpun, AS Hamy, ...
ESMO open 6 (6), 100300, 2021
How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2)
G Montagna, D Anderson, J Bochenek-Cibor, I Bozovic-Spasojevic, ...
The Breast 43, 18-21, 2019
microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study
M Kunc, M Popęda, A Szałkowska, M Niemira, M Bieńkowski, R Pęksa, ...
Diagnostics 10 (9), 617, 2020
High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of …
M Kunc, R Pęksa, G Cserni, E Iżycka-Świeszewska, A Łacko, B Radecka, ...
Pathology 54 (3), 269-278, 2022
Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas
N Bednarz-Knoll, M Popęda, T Kryczka, B Kozakiewicz, K Pogoda, ...
British Journal of Cancer 126 (3), 464-471, 2022
Metronomic chemotherapy in breast cancer
K Pogoda, M Krzakowski, A Jagiełło-Gruszfeld
Oncology in Clinical Practice 13 (4), 161-168, 2017
The outcome of special histologic types of triple-negative breast cancer (TNBC).
K Pogoda, A Niwinska, M Murawska, W Olszewski, Z Nowecki
Journal of Clinical Oncology 32 (15_suppl), 1122-1122, 2014
Nie można teraz wykonać tej operacji. Spróbuj ponownie później.
Prace 1–20